Rare diseases
Investigational molecules
Locations
Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study
FranceStudy on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations
FranceStudy of Lower Dose Olaparib Combined with Cobicistat to Improve Treatment Tolerance in Cancer Patients
The NetherlandsStudy on Modified Osimertinib Dosing with Cobicistat for Advanced Non-Small Cell Lung Cancer in Patients with EGFR Mutation
The NetherlandsStudy on Cobicistat, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
The NetherlandsStudy on Switching to Doravirine and Islatravir for People with HIV-1 on Antiretroviral Therapy
FranceStudy on HIV Treatment Interruption in Children with Perinatal HIV Using Lamivudine and Drug Combination
ItalyStudy Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load
GermanyStudy Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
